Figure 4.
Pathway enrichment and pathway impact analysis. (A) Pathway enrichment analysis of WGCNA results from combined LC/GC-MS data. (B) Pathway impact analysis of WGCNA results from combined LC/GC-MS data. (C) Pathway enrichment analysis of positive metabolites from MR analysis. (D) Pathway impact analysis of positive metabolites from MR analysis. (E) Pathway enrichment analysis of metabolites from LC/GC-MS, WGCNA metabolites, and MR-positive metabolites. (F) Pathway impact analysis of metabolites from LC/GC-MS, WGCNA metabolites, and MR-positive metabolites.
